Amdocs
DOX
58.74
+0.25
+0.43%
Amdocs
US · DOX
#1914 by market cap
Listed 1970
58.74
+0.25
+0.43%
Live - 5344 symbols - heartbeat 524s ago
· 2026-10-08 08:06
Pre-market
58.75
+0.02%
After-hours
58.74
0.00%
- Market cap
- 6.13B
- P/E (TTM)i
- 13.95
- P/Bi
- 1.90
- EPSi
- 5.05
- Div yieldi
- 3.73%
- 52W posi
- 30%
Reader sentiment
Are you bullish or bearish on DOX?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 3 in the most recent period (2026/Q3).
- Total institutional ownership (as a % of shares) was little changed.
Institutional ownership
- Held by institutions
- 102.38% -0.09pp
- Institutions
- 554 -3
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund88.97%
Hedge Fund6.34%
Public Company3.79%
Private Company2.06%
Individual/Insider1.22%
Government Pension Fund0.89%
Family Office/Trust0.19%
Top holders as of 2026-06-30
Pzena Investment Management, Inc.
13.39% · 13.99M sh
FMR
8.41% · 8.78M sh
Beutel Goodman & Company Ltd.
4.42% · 4.61M sh
Brandes Investment Partners, LP
4.39% · 4.58M sh
LSV Asset Management
4.32% · 4.51M sh
BlackRock
4.19% · 4.38M sh
Dimensional Fund Advisors
3.92% · 4.10M sh
Federated Hermes, Inc.
3.01% · 3.14M sh
Vanguard Portfolio Management, LLC
2.64% · 2.75M sh
AQR Capital Management
2.52% · 2.63M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
24 filings tracked · 1 buys · 8 sells
| Name | Role | Stake |
|---|---|---|
| Eli Gelman | Director | 0.33% |
| Robert Minicucci | Independent Chairperson | 0.29% |
| Tamar Rapaport-Dagim | Chief Financial Officer | 0.28% |
| Shimie Hortig | Group President of the Americas Business Group | 0.17% |
| Adrian David Gardner | Independent Director | 0.05% |
| Ralph De la Vega | -- | 0.03% |
| Yvette Gordon-Kanouff | Independent Director | 0.02% |
| Tal Rozenfeld | GM & Head of Finance | 0.02% |
| Sarah Davis | Independent Director | 0.02% |
| Matthew Smith | Secretary & Head of Investor Relations | 0.00% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-07-27 | Tamar Rapaport-Dagim | Chief Financial Officer | Intent to Sell (Form 144) | -12,780 | $53.10 |
| 2026-07-22 | Tamar Rapaport-Dagim | Chief Financial Officer | Intent to Sell (Form 144) | -107,577 | $51.22 |
| 2026-05-31 | Tal Rozenfeld | GM & Head of Finance | Initial Statement of Beneficial | 0 | -- |
| 2026-05-28 | Matthew Smith | Secretary & Head of Investor Relations | Open Market Disposition | -464 | $62.51 |
| 2026-05-12 | Shimie Hortig | Group President of the Americas Business Group | Other Acquisition | +84,483 | -- |
| 2026-03-30 | Shimie Hortig | Group President of the Americas Business Group | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Robert Minicucci | Independent Chairperson | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | John MacDonald | Independent Director | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Adrian David Gardner | Independent Director | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Véronique Morali | Director | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Eli Gelman | Director | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Tamar Rapaport-Dagim | Chief Financial Officer | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Ralph De la Vega | -- | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Amos Genish | Director | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Matthew Smith | Secretary & Head of Investor Relations | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Sarah Davis | Independent Director | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Yvette Gordon-Kanouff | Independent Director | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Rajat Raheja | Division President of Amdocs Development Centre India LLP | Initial Statement of Beneficial | 0 | -- |
| 2025-09-01 | Rajat Raheja | Division President of Amdocs Development Centre India LLP | Intent to Sell (Form 144) | -2,285 | $85.50 |
| 2025-02-27 | Matthew Smith | Secretary & Head of Investor Relations | Intent to Sell (Form 144) | -525 | $87.74 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 08:06:14 · For reference only, not investment advice and not tailored to your situation.